nodes	percent_of_prediction	percent_of_DWPC	metapath
Rivaroxaban—ABCB1—Ticagrelor—coronary artery disease	0.036	0.0593	CbGbCtD
Rivaroxaban—CYP3A5—Clopidogrel—coronary artery disease	0.0341	0.0563	CbGbCtD
Rivaroxaban—CYP3A5—Eplerenone—coronary artery disease	0.0317	0.0523	CbGbCtD
Rivaroxaban—ABCB1—Clopidogrel—coronary artery disease	0.0222	0.0366	CbGbCtD
Rivaroxaban—ABCB1—Perindopril—coronary artery disease	0.0222	0.0366	CbGbCtD
Rivaroxaban—CYP3A5—Rosuvastatin—coronary artery disease	0.022	0.0363	CbGbCtD
Rivaroxaban—CYP3A4—Ticagrelor—coronary artery disease	0.0215	0.0355	CbGbCtD
Rivaroxaban—CYP3A5—Simvastatin—coronary artery disease	0.0204	0.0337	CbGbCtD
Rivaroxaban—CYP3A5—Pravastatin—coronary artery disease	0.02	0.033	CbGbCtD
Rivaroxaban—CYP3A5—Lovastatin—coronary artery disease	0.02	0.033	CbGbCtD
Rivaroxaban—ABCB1—Telmisartan—coronary artery disease	0.0194	0.032	CbGbCtD
Rivaroxaban—ABCB1—Pitavastatin—coronary artery disease	0.0194	0.032	CbGbCtD
Rivaroxaban—CYP3A4—Fenofibrate—coronary artery disease	0.0192	0.0317	CbGbCtD
Rivaroxaban—ABCB1—Enalapril—coronary artery disease	0.0184	0.0304	CbGbCtD
Rivaroxaban—ABCB1—Lisinopril—coronary artery disease	0.0184	0.0304	CbGbCtD
Rivaroxaban—CYP3A5—Atorvastatin—coronary artery disease	0.0182	0.0301	CbGbCtD
Rivaroxaban—CYP3A5—Losartan—coronary artery disease	0.0167	0.0275	CbGbCtD
Rivaroxaban—ABCB1—Timolol—coronary artery disease	0.0157	0.0258	CbGbCtD
Rivaroxaban—CYP3A4—Gemfibrozil—coronary artery disease	0.0154	0.0253	CbGbCtD
Rivaroxaban—ABCB1—Ezetimibe—coronary artery disease	0.0143	0.0236	CbGbCtD
Rivaroxaban—ABCB1—Acetylsalicylic acid—coronary artery disease	0.0139	0.023	CbGbCtD
Rivaroxaban—ABCB1—Captopril—coronary artery disease	0.0138	0.0227	CbGbCtD
Rivaroxaban—CYP3A4—Clopidogrel—coronary artery disease	0.0133	0.022	CbGbCtD
Rivaroxaban—ABCB1—Simvastatin—coronary artery disease	0.0133	0.022	CbGbCtD
Rivaroxaban—ABCB1—Pravastatin—coronary artery disease	0.013	0.0215	CbGbCtD
Rivaroxaban—ABCB1—Lovastatin—coronary artery disease	0.013	0.0215	CbGbCtD
Rivaroxaban—CYP3A4—Eplerenone—coronary artery disease	0.0124	0.0204	CbGbCtD
Rivaroxaban—ABCB1—Atorvastatin—coronary artery disease	0.0119	0.0196	CbGbCtD
Rivaroxaban—CYP3A4—Enalapril—coronary artery disease	0.011	0.0182	CbGbCtD
Rivaroxaban—ABCB1—Losartan—coronary artery disease	0.0108	0.0179	CbGbCtD
Rivaroxaban—CYP3A4—Rosuvastatin—coronary artery disease	0.00858	0.0141	CbGbCtD
Rivaroxaban—CYP3A4—Ezetimibe—coronary artery disease	0.00858	0.0141	CbGbCtD
Rivaroxaban—CYP3A4—Simvastatin—coronary artery disease	0.00797	0.0132	CbGbCtD
Rivaroxaban—CYP3A4—Lovastatin—coronary artery disease	0.0078	0.0129	CbGbCtD
Rivaroxaban—CYP3A4—Pravastatin—coronary artery disease	0.0078	0.0129	CbGbCtD
Rivaroxaban—CYP3A4—Atorvastatin—coronary artery disease	0.00711	0.0117	CbGbCtD
Rivaroxaban—CYP3A4—Losartan—coronary artery disease	0.0065	0.0107	CbGbCtD
Rivaroxaban—CYP2J2—artery—coronary artery disease	0.00304	0.197	CbGeAlD
Rivaroxaban—CYP2J2—cardiac ventricle—coronary artery disease	0.00171	0.111	CbGeAlD
Rivaroxaban—CYP2J2—myocardium—coronary artery disease	0.0016	0.104	CbGeAlD
Rivaroxaban—F10—heart—coronary artery disease	0.00137	0.0887	CbGeAlD
Rivaroxaban—F10—cardiovascular system—coronary artery disease	0.00129	0.0837	CbGeAlD
Rivaroxaban—F10—cardiac atrium—coronary artery disease	0.00117	0.0758	CbGeAlD
Rivaroxaban—CYP2J2—heart—coronary artery disease	0.00112	0.0727	CbGeAlD
Rivaroxaban—CYP2J2—cardiovascular system—coronary artery disease	0.00106	0.0686	CbGeAlD
Rivaroxaban—F10—blood—coronary artery disease	0.00102	0.0662	CbGeAlD
Rivaroxaban—CYP2J2—cardiac atrium—coronary artery disease	0.000958	0.0622	CbGeAlD
Rivaroxaban—CYP3A5—blood—coronary artery disease	0.000294	0.0191	CbGeAlD
Rivaroxaban—CYP3A4—blood—coronary artery disease	0.000221	0.0143	CbGeAlD
Rivaroxaban—ABCB1—heart—coronary artery disease	0.000209	0.0136	CbGeAlD
Rivaroxaban—ABCB1—cardiovascular system—coronary artery disease	0.000198	0.0128	CbGeAlD
Rivaroxaban—ABCB1—blood—coronary artery disease	0.000156	0.0101	CbGeAlD
Rivaroxaban—Abdominal pain—Telmisartan—coronary artery disease	8.85e-05	0.000367	CcSEcCtD
Rivaroxaban—Dyspnoea—Losartan—coronary artery disease	8.84e-05	0.000367	CcSEcCtD
Rivaroxaban—Vomiting—Lovastatin—coronary artery disease	8.82e-05	0.000366	CcSEcCtD
Rivaroxaban—Dizziness—Eplerenone—coronary artery disease	8.81e-05	0.000365	CcSEcCtD
Rivaroxaban—Rash—Clopidogrel—coronary artery disease	8.81e-05	0.000365	CcSEcCtD
Rivaroxaban—Unspecified disorder of skin and subcutaneous tissue—Ramipril—coronary artery disease	8.8e-05	0.000365	CcSEcCtD
Rivaroxaban—Dermatitis—Clopidogrel—coronary artery disease	8.8e-05	0.000365	CcSEcCtD
Rivaroxaban—Asthenia—Valsartan—coronary artery disease	8.79e-05	0.000365	CcSEcCtD
Rivaroxaban—Constipation—Furosemide—coronary artery disease	8.78e-05	0.000364	CcSEcCtD
Rivaroxaban—Pain—Furosemide—coronary artery disease	8.78e-05	0.000364	CcSEcCtD
Rivaroxaban—Hypersensitivity—Niacin—coronary artery disease	8.78e-05	0.000364	CcSEcCtD
Rivaroxaban—Ill-defined disorder—Lisinopril—coronary artery disease	8.76e-05	0.000364	CcSEcCtD
Rivaroxaban—Discomfort—Ramipril—coronary artery disease	8.76e-05	0.000363	CcSEcCtD
Rivaroxaban—Asthenia—Olmesartan—coronary artery disease	8.75e-05	0.000363	CcSEcCtD
Rivaroxaban—Headache—Clopidogrel—coronary artery disease	8.75e-05	0.000363	CcSEcCtD
Rivaroxaban—Rash—Lovastatin—coronary artery disease	8.75e-05	0.000363	CcSEcCtD
Rivaroxaban—Dermatitis—Lovastatin—coronary artery disease	8.74e-05	0.000363	CcSEcCtD
Rivaroxaban—Anaemia—Lisinopril—coronary artery disease	8.73e-05	0.000362	CcSEcCtD
Rivaroxaban—Dyspepsia—Losartan—coronary artery disease	8.72e-05	0.000362	CcSEcCtD
Rivaroxaban—Feeling abnormal—Perindopril—coronary artery disease	8.71e-05	0.000361	CcSEcCtD
Rivaroxaban—Headache—Lovastatin—coronary artery disease	8.69e-05	0.000361	CcSEcCtD
Rivaroxaban—Pruritus—Valsartan—coronary artery disease	8.67e-05	0.00036	CcSEcCtD
Rivaroxaban—Dry mouth—Ramipril—coronary artery disease	8.67e-05	0.00036	CcSEcCtD
Rivaroxaban—Chest pain—Timolol—coronary artery disease	8.67e-05	0.00036	CcSEcCtD
Rivaroxaban—Vomiting—Ezetimibe—coronary artery disease	8.65e-05	0.000359	CcSEcCtD
Rivaroxaban—Hypersensitivity—Pravastatin—coronary artery disease	8.64e-05	0.000359	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Perindopril—coronary artery disease	8.64e-05	0.000359	CcSEcCtD
Rivaroxaban—Angioedema—Lisinopril—coronary artery disease	8.63e-05	0.000358	CcSEcCtD
Rivaroxaban—Pruritus—Olmesartan—coronary artery disease	8.63e-05	0.000358	CcSEcCtD
Rivaroxaban—Unspecified disorder of skin and subcutaneous tissue—Timolol—coronary artery disease	8.61e-05	0.000357	CcSEcCtD
Rivaroxaban—Abdominal pain—Captopril—coronary artery disease	8.6e-05	0.000357	CcSEcCtD
Rivaroxaban—Dizziness—Simvastatin—coronary artery disease	8.58e-05	0.000356	CcSEcCtD
Rivaroxaban—Rash—Ezetimibe—coronary artery disease	8.58e-05	0.000356	CcSEcCtD
Rivaroxaban—Dermatitis—Ezetimibe—coronary artery disease	8.57e-05	0.000356	CcSEcCtD
Rivaroxaban—Discomfort—Timolol—coronary artery disease	8.56e-05	0.000355	CcSEcCtD
Rivaroxaban—Asthenia—Niacin—coronary artery disease	8.55e-05	0.000355	CcSEcCtD
Rivaroxaban—Fatigue—Losartan—coronary artery disease	8.55e-05	0.000355	CcSEcCtD
Rivaroxaban—Headache—Ezetimibe—coronary artery disease	8.52e-05	0.000354	CcSEcCtD
Rivaroxaban—Malaise—Lisinopril—coronary artery disease	8.52e-05	0.000353	CcSEcCtD
Rivaroxaban—Anaphylactic shock—Ramipril—coronary artery disease	8.5e-05	0.000353	CcSEcCtD
Rivaroxaban—Oedema—Ramipril—coronary artery disease	8.5e-05	0.000353	CcSEcCtD
Rivaroxaban—Dry mouth—Timolol—coronary artery disease	8.48e-05	0.000352	CcSEcCtD
Rivaroxaban—Constipation—Losartan—coronary artery disease	8.48e-05	0.000352	CcSEcCtD
Rivaroxaban—Pain—Losartan—coronary artery disease	8.48e-05	0.000352	CcSEcCtD
Rivaroxaban—Syncope—Lisinopril—coronary artery disease	8.47e-05	0.000351	CcSEcCtD
Rivaroxaban—Vomiting—Eplerenone—coronary artery disease	8.47e-05	0.000351	CcSEcCtD
Rivaroxaban—Feeling abnormal—Furosemide—coronary artery disease	8.47e-05	0.000351	CcSEcCtD
Rivaroxaban—Nausea—Fenofibrate—coronary artery disease	8.44e-05	0.00035	CcSEcCtD
Rivaroxaban—Pruritus—Niacin—coronary artery disease	8.43e-05	0.00035	CcSEcCtD
Rivaroxaban—Asthenia—Pravastatin—coronary artery disease	8.42e-05	0.000349	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Furosemide—coronary artery disease	8.4e-05	0.000349	CcSEcCtD
Rivaroxaban—Rash—Eplerenone—coronary artery disease	8.4e-05	0.000348	CcSEcCtD
Rivaroxaban—Urticaria—Perindopril—coronary artery disease	8.39e-05	0.000348	CcSEcCtD
Rivaroxaban—Hypersensitivity—Trandolapril—coronary artery disease	8.39e-05	0.000348	CcSEcCtD
Rivaroxaban—Dermatitis—Eplerenone—coronary artery disease	8.39e-05	0.000348	CcSEcCtD
Rivaroxaban—Diarrhoea—Valsartan—coronary artery disease	8.38e-05	0.000348	CcSEcCtD
Rivaroxaban—Shock—Ramipril—coronary artery disease	8.36e-05	0.000347	CcSEcCtD
Rivaroxaban—Hypersensitivity—Enalapril—coronary artery disease	8.36e-05	0.000347	CcSEcCtD
Rivaroxaban—Abdominal pain—Perindopril—coronary artery disease	8.35e-05	0.000347	CcSEcCtD
Rivaroxaban—Diarrhoea—Olmesartan—coronary artery disease	8.34e-05	0.000346	CcSEcCtD
Rivaroxaban—Headache—Eplerenone—coronary artery disease	8.34e-05	0.000346	CcSEcCtD
Rivaroxaban—Nervous system disorder—Ramipril—coronary artery disease	8.33e-05	0.000346	CcSEcCtD
Rivaroxaban—Oedema—Timolol—coronary artery disease	8.31e-05	0.000345	CcSEcCtD
Rivaroxaban—Anaphylactic shock—Timolol—coronary artery disease	8.31e-05	0.000345	CcSEcCtD
Rivaroxaban—Pruritus—Pravastatin—coronary artery disease	8.3e-05	0.000344	CcSEcCtD
Rivaroxaban—Loss of consciousness—Lisinopril—coronary artery disease	8.3e-05	0.000344	CcSEcCtD
Rivaroxaban—Nausea—Clopidogrel—coronary artery disease	8.3e-05	0.000344	CcSEcCtD
Rivaroxaban—Tachycardia—Ramipril—coronary artery disease	8.29e-05	0.000344	CcSEcCtD
Rivaroxaban—Skin disorder—Ramipril—coronary artery disease	8.25e-05	0.000343	CcSEcCtD
Rivaroxaban—Infection—Timolol—coronary artery disease	8.25e-05	0.000342	CcSEcCtD
Rivaroxaban—Vomiting—Simvastatin—coronary artery disease	8.25e-05	0.000342	CcSEcCtD
Rivaroxaban—Hypersensitivity—Telmisartan—coronary artery disease	8.25e-05	0.000342	CcSEcCtD
Rivaroxaban—Nausea—Lovastatin—coronary artery disease	8.24e-05	0.000342	CcSEcCtD
Rivaroxaban—Rash—Simvastatin—coronary artery disease	8.18e-05	0.000339	CcSEcCtD
Rivaroxaban—Dermatitis—Simvastatin—coronary artery disease	8.17e-05	0.000339	CcSEcCtD
Rivaroxaban—Asthenia—Trandolapril—coronary artery disease	8.17e-05	0.000339	CcSEcCtD
Rivaroxaban—Shock—Timolol—coronary artery disease	8.17e-05	0.000339	CcSEcCtD
Rivaroxaban—Feeling abnormal—Losartan—coronary artery disease	8.17e-05	0.000339	CcSEcCtD
Rivaroxaban—Urticaria—Furosemide—coronary artery disease	8.16e-05	0.000339	CcSEcCtD
Rivaroxaban—Diarrhoea—Niacin—coronary artery disease	8.15e-05	0.000338	CcSEcCtD
Rivaroxaban—Nervous system disorder—Timolol—coronary artery disease	8.15e-05	0.000338	CcSEcCtD
Rivaroxaban—Asthenia—Enalapril—coronary artery disease	8.14e-05	0.000338	CcSEcCtD
Rivaroxaban—Headache—Simvastatin—coronary artery disease	8.13e-05	0.000337	CcSEcCtD
Rivaroxaban—Abdominal pain—Furosemide—coronary artery disease	8.12e-05	0.000337	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Losartan—coronary artery disease	8.1e-05	0.000336	CcSEcCtD
Rivaroxaban—Dizziness—Valsartan—coronary artery disease	8.1e-05	0.000336	CcSEcCtD
Rivaroxaban—Nausea—Ezetimibe—coronary artery disease	8.08e-05	0.000335	CcSEcCtD
Rivaroxaban—Skin disorder—Timolol—coronary artery disease	8.07e-05	0.000335	CcSEcCtD
Rivaroxaban—Dizziness—Olmesartan—coronary artery disease	8.07e-05	0.000335	CcSEcCtD
Rivaroxaban—Pruritus—Trandolapril—coronary artery disease	8.06e-05	0.000334	CcSEcCtD
Rivaroxaban—Chest pain—Lisinopril—coronary artery disease	8.04e-05	0.000334	CcSEcCtD
Rivaroxaban—Asthenia—Telmisartan—coronary artery disease	8.03e-05	0.000333	CcSEcCtD
Rivaroxaban—Pruritus—Enalapril—coronary artery disease	8.03e-05	0.000333	CcSEcCtD
Rivaroxaban—Diarrhoea—Pravastatin—coronary artery disease	8.03e-05	0.000333	CcSEcCtD
Rivaroxaban—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	7.98e-05	0.000331	CcSEcCtD
Rivaroxaban—Discomfort—Lisinopril—coronary artery disease	7.94e-05	0.00033	CcSEcCtD
Rivaroxaban—Hypotension—Ramipril—coronary artery disease	7.94e-05	0.000329	CcSEcCtD
Rivaroxaban—Pruritus—Telmisartan—coronary artery disease	7.92e-05	0.000329	CcSEcCtD
Rivaroxaban—Nausea—Eplerenone—coronary artery disease	7.91e-05	0.000328	CcSEcCtD
Rivaroxaban—Dizziness—Niacin—coronary artery disease	7.88e-05	0.000327	CcSEcCtD
Rivaroxaban—Urticaria—Losartan—coronary artery disease	7.87e-05	0.000327	CcSEcCtD
Rivaroxaban—Dry mouth—Lisinopril—coronary artery disease	7.86e-05	0.000326	CcSEcCtD
Rivaroxaban—Abdominal pain—Losartan—coronary artery disease	7.84e-05	0.000325	CcSEcCtD
Rivaroxaban—Asthenia—Captopril—coronary artery disease	7.81e-05	0.000324	CcSEcCtD
Rivaroxaban—Diarrhoea—Trandolapril—coronary artery disease	7.8e-05	0.000323	CcSEcCtD
Rivaroxaban—Vomiting—Valsartan—coronary artery disease	7.79e-05	0.000323	CcSEcCtD
Rivaroxaban—Diarrhoea—Enalapril—coronary artery disease	7.76e-05	0.000322	CcSEcCtD
Rivaroxaban—Hypotension—Timolol—coronary artery disease	7.76e-05	0.000322	CcSEcCtD
Rivaroxaban—Dizziness—Pravastatin—coronary artery disease	7.76e-05	0.000322	CcSEcCtD
Rivaroxaban—Vomiting—Olmesartan—coronary artery disease	7.75e-05	0.000322	CcSEcCtD
Rivaroxaban—Rash—Valsartan—coronary artery disease	7.73e-05	0.000321	CcSEcCtD
Rivaroxaban—Dermatitis—Valsartan—coronary artery disease	7.72e-05	0.00032	CcSEcCtD
Rivaroxaban—Nausea—Simvastatin—coronary artery disease	7.71e-05	0.00032	CcSEcCtD
Rivaroxaban—Anaphylactic shock—Lisinopril—coronary artery disease	7.71e-05	0.00032	CcSEcCtD
Rivaroxaban—Oedema—Lisinopril—coronary artery disease	7.71e-05	0.00032	CcSEcCtD
Rivaroxaban—Pruritus—Captopril—coronary artery disease	7.7e-05	0.000319	CcSEcCtD
Rivaroxaban—Rash—Olmesartan—coronary artery disease	7.69e-05	0.000319	CcSEcCtD
Rivaroxaban—Dermatitis—Olmesartan—coronary artery disease	7.68e-05	0.000319	CcSEcCtD
Rivaroxaban—Headache—Valsartan—coronary artery disease	7.68e-05	0.000319	CcSEcCtD
Rivaroxaban—Diarrhoea—Telmisartan—coronary artery disease	7.66e-05	0.000318	CcSEcCtD
Rivaroxaban—Infection—Lisinopril—coronary artery disease	7.66e-05	0.000318	CcSEcCtD
Rivaroxaban—Headache—Olmesartan—coronary artery disease	7.64e-05	0.000317	CcSEcCtD
Rivaroxaban—Shock—Lisinopril—coronary artery disease	7.58e-05	0.000315	CcSEcCtD
Rivaroxaban—Asthenia—Perindopril—coronary artery disease	7.58e-05	0.000315	CcSEcCtD
Rivaroxaban—Dyspnoea—Ramipril—coronary artery disease	7.58e-05	0.000314	CcSEcCtD
Rivaroxaban—Vomiting—Niacin—coronary artery disease	7.58e-05	0.000314	CcSEcCtD
Rivaroxaban—Hypersensitivity—Furosemide—coronary artery disease	7.57e-05	0.000314	CcSEcCtD
Rivaroxaban—Dizziness—Trandolapril—coronary artery disease	7.53e-05	0.000313	CcSEcCtD
Rivaroxaban—Tachycardia—Lisinopril—coronary artery disease	7.52e-05	0.000312	CcSEcCtD
Rivaroxaban—Rash—Niacin—coronary artery disease	7.51e-05	0.000312	CcSEcCtD
Rivaroxaban—Dermatitis—Niacin—coronary artery disease	7.51e-05	0.000311	CcSEcCtD
Rivaroxaban—Dizziness—Enalapril—coronary artery disease	7.5e-05	0.000311	CcSEcCtD
Rivaroxaban—Skin disorder—Lisinopril—coronary artery disease	7.49e-05	0.000311	CcSEcCtD
Rivaroxaban—Dyspepsia—Ramipril—coronary artery disease	7.48e-05	0.00031	CcSEcCtD
Rivaroxaban—Pruritus—Perindopril—coronary artery disease	7.48e-05	0.00031	CcSEcCtD
Rivaroxaban—Headache—Niacin—coronary artery disease	7.46e-05	0.00031	CcSEcCtD
Rivaroxaban—Vomiting—Pravastatin—coronary artery disease	7.46e-05	0.000309	CcSEcCtD
Rivaroxaban—Diarrhoea—Captopril—coronary artery disease	7.45e-05	0.000309	CcSEcCtD
Rivaroxaban—Dyspnoea—Timolol—coronary artery disease	7.41e-05	0.000307	CcSEcCtD
Rivaroxaban—Dizziness—Telmisartan—coronary artery disease	7.4e-05	0.000307	CcSEcCtD
Rivaroxaban—Rash—Pravastatin—coronary artery disease	7.4e-05	0.000307	CcSEcCtD
Rivaroxaban—Dermatitis—Pravastatin—coronary artery disease	7.39e-05	0.000307	CcSEcCtD
Rivaroxaban—Asthenia—Furosemide—coronary artery disease	7.37e-05	0.000306	CcSEcCtD
Rivaroxaban—Headache—Pravastatin—coronary artery disease	7.35e-05	0.000305	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Ramipril—coronary artery disease	7.34e-05	0.000304	CcSEcCtD
Rivaroxaban—Fatigue—Ramipril—coronary artery disease	7.33e-05	0.000304	CcSEcCtD
Rivaroxaban—Dyspepsia—Timolol—coronary artery disease	7.31e-05	0.000303	CcSEcCtD
Rivaroxaban—Hypersensitivity—Losartan—coronary artery disease	7.3e-05	0.000303	CcSEcCtD
Rivaroxaban—Nausea—Valsartan—coronary artery disease	7.28e-05	0.000302	CcSEcCtD
Rivaroxaban—Pruritus—Furosemide—coronary artery disease	7.27e-05	0.000302	CcSEcCtD
Rivaroxaban—Constipation—Ramipril—coronary artery disease	7.27e-05	0.000302	CcSEcCtD
Rivaroxaban—Nausea—Olmesartan—coronary artery disease	7.24e-05	0.000301	CcSEcCtD
Rivaroxaban—Vomiting—Trandolapril—coronary artery disease	7.24e-05	0.000301	CcSEcCtD
Rivaroxaban—Diarrhoea—Perindopril—coronary artery disease	7.23e-05	0.0003	CcSEcCtD
Rivaroxaban—Vomiting—Enalapril—coronary artery disease	7.21e-05	0.000299	CcSEcCtD
Rivaroxaban—Hypotension—Lisinopril—coronary artery disease	7.2e-05	0.000299	CcSEcCtD
Rivaroxaban—Dizziness—Captopril—coronary artery disease	7.2e-05	0.000299	CcSEcCtD
Rivaroxaban—Rash—Trandolapril—coronary artery disease	7.18e-05	0.000298	CcSEcCtD
Rivaroxaban—Dermatitis—Trandolapril—coronary artery disease	7.18e-05	0.000298	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Timolol—coronary artery disease	7.17e-05	0.000298	CcSEcCtD
Rivaroxaban—Fatigue—Timolol—coronary artery disease	7.16e-05	0.000297	CcSEcCtD
Rivaroxaban—Rash—Enalapril—coronary artery disease	7.15e-05	0.000297	CcSEcCtD
Rivaroxaban—Dermatitis—Enalapril—coronary artery disease	7.15e-05	0.000297	CcSEcCtD
Rivaroxaban—Headache—Trandolapril—coronary artery disease	7.14e-05	0.000296	CcSEcCtD
Rivaroxaban—Vomiting—Telmisartan—coronary artery disease	7.12e-05	0.000295	CcSEcCtD
Rivaroxaban—Asthenia—Losartan—coronary artery disease	7.11e-05	0.000295	CcSEcCtD
Rivaroxaban—Headache—Enalapril—coronary artery disease	7.11e-05	0.000295	CcSEcCtD
Rivaroxaban—Pain—Timolol—coronary artery disease	7.1e-05	0.000295	CcSEcCtD
Rivaroxaban—Nausea—Niacin—coronary artery disease	7.08e-05	0.000294	CcSEcCtD
Rivaroxaban—Rash—Telmisartan—coronary artery disease	7.06e-05	0.000293	CcSEcCtD
Rivaroxaban—Dermatitis—Telmisartan—coronary artery disease	7.05e-05	0.000293	CcSEcCtD
Rivaroxaban—Diarrhoea—Furosemide—coronary artery disease	7.03e-05	0.000292	CcSEcCtD
Rivaroxaban—Pruritus—Losartan—coronary artery disease	7.01e-05	0.000291	CcSEcCtD
Rivaroxaban—Headache—Telmisartan—coronary artery disease	7.01e-05	0.000291	CcSEcCtD
Rivaroxaban—Feeling abnormal—Ramipril—coronary artery disease	7e-05	0.000291	CcSEcCtD
Rivaroxaban—Dizziness—Perindopril—coronary artery disease	6.99e-05	0.00029	CcSEcCtD
Rivaroxaban—Nausea—Pravastatin—coronary artery disease	6.97e-05	0.000289	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Ramipril—coronary artery disease	6.95e-05	0.000288	CcSEcCtD
Rivaroxaban—Vomiting—Captopril—coronary artery disease	6.92e-05	0.000287	CcSEcCtD
Rivaroxaban—Dyspnoea—Lisinopril—coronary artery disease	6.87e-05	0.000285	CcSEcCtD
Rivaroxaban—Rash—Captopril—coronary artery disease	6.86e-05	0.000285	CcSEcCtD
Rivaroxaban—Dermatitis—Captopril—coronary artery disease	6.86e-05	0.000284	CcSEcCtD
Rivaroxaban—Feeling abnormal—Timolol—coronary artery disease	6.85e-05	0.000284	CcSEcCtD
Rivaroxaban—Headache—Captopril—coronary artery disease	6.82e-05	0.000283	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Timolol—coronary artery disease	6.79e-05	0.000282	CcSEcCtD
Rivaroxaban—Dizziness—Furosemide—coronary artery disease	6.79e-05	0.000282	CcSEcCtD
Rivaroxaban—Dyspepsia—Lisinopril—coronary artery disease	6.78e-05	0.000281	CcSEcCtD
Rivaroxaban—Diarrhoea—Losartan—coronary artery disease	6.78e-05	0.000281	CcSEcCtD
Rivaroxaban—Nausea—Trandolapril—coronary artery disease	6.77e-05	0.000281	CcSEcCtD
Rivaroxaban—Urticaria—Ramipril—coronary artery disease	6.75e-05	0.00028	CcSEcCtD
Rivaroxaban—Nausea—Enalapril—coronary artery disease	6.74e-05	0.00028	CcSEcCtD
Rivaroxaban—Vomiting—Perindopril—coronary artery disease	6.72e-05	0.000279	CcSEcCtD
Rivaroxaban—Abdominal pain—Ramipril—coronary artery disease	6.72e-05	0.000279	CcSEcCtD
Rivaroxaban—Rash—Perindopril—coronary artery disease	6.66e-05	0.000276	CcSEcCtD
Rivaroxaban—Dermatitis—Perindopril—coronary artery disease	6.66e-05	0.000276	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Lisinopril—coronary artery disease	6.65e-05	0.000276	CcSEcCtD
Rivaroxaban—Nausea—Telmisartan—coronary artery disease	6.65e-05	0.000276	CcSEcCtD
Rivaroxaban—Fatigue—Lisinopril—coronary artery disease	6.65e-05	0.000276	CcSEcCtD
Rivaroxaban—Headache—Perindopril—coronary artery disease	6.62e-05	0.000275	CcSEcCtD
Rivaroxaban—Urticaria—Timolol—coronary artery disease	6.6e-05	0.000274	CcSEcCtD
Rivaroxaban—Constipation—Lisinopril—coronary artery disease	6.59e-05	0.000273	CcSEcCtD
Rivaroxaban—Pain—Lisinopril—coronary artery disease	6.59e-05	0.000273	CcSEcCtD
Rivaroxaban—Abdominal pain—Timolol—coronary artery disease	6.57e-05	0.000273	CcSEcCtD
Rivaroxaban—Dizziness—Losartan—coronary artery disease	6.55e-05	0.000272	CcSEcCtD
Rivaroxaban—Vomiting—Furosemide—coronary artery disease	6.53e-05	0.000271	CcSEcCtD
Rivaroxaban—Rash—Furosemide—coronary artery disease	6.48e-05	0.000269	CcSEcCtD
Rivaroxaban—Dermatitis—Furosemide—coronary artery disease	6.47e-05	0.000268	CcSEcCtD
Rivaroxaban—Nausea—Captopril—coronary artery disease	6.46e-05	0.000268	CcSEcCtD
Rivaroxaban—Headache—Furosemide—coronary artery disease	6.44e-05	0.000267	CcSEcCtD
Rivaroxaban—Feeling abnormal—Lisinopril—coronary artery disease	6.35e-05	0.000264	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Lisinopril—coronary artery disease	6.3e-05	0.000261	CcSEcCtD
Rivaroxaban—Vomiting—Losartan—coronary artery disease	6.3e-05	0.000261	CcSEcCtD
Rivaroxaban—Nausea—Perindopril—coronary artery disease	6.28e-05	0.00026	CcSEcCtD
Rivaroxaban—Hypersensitivity—Ramipril—coronary artery disease	6.26e-05	0.00026	CcSEcCtD
Rivaroxaban—Rash—Losartan—coronary artery disease	6.25e-05	0.000259	CcSEcCtD
Rivaroxaban—Dermatitis—Losartan—coronary artery disease	6.24e-05	0.000259	CcSEcCtD
Rivaroxaban—Headache—Losartan—coronary artery disease	6.21e-05	0.000258	CcSEcCtD
Rivaroxaban—Urticaria—Lisinopril—coronary artery disease	6.12e-05	0.000254	CcSEcCtD
Rivaroxaban—Hypersensitivity—Timolol—coronary artery disease	6.12e-05	0.000254	CcSEcCtD
Rivaroxaban—Nausea—Furosemide—coronary artery disease	6.1e-05	0.000253	CcSEcCtD
Rivaroxaban—Asthenia—Ramipril—coronary artery disease	6.1e-05	0.000253	CcSEcCtD
Rivaroxaban—Abdominal pain—Lisinopril—coronary artery disease	6.09e-05	0.000253	CcSEcCtD
Rivaroxaban—Pruritus—Ramipril—coronary artery disease	6.01e-05	0.000249	CcSEcCtD
Rivaroxaban—Asthenia—Timolol—coronary artery disease	5.96e-05	0.000247	CcSEcCtD
Rivaroxaban—Nausea—Losartan—coronary artery disease	5.89e-05	0.000244	CcSEcCtD
Rivaroxaban—Pruritus—Timolol—coronary artery disease	5.88e-05	0.000244	CcSEcCtD
Rivaroxaban—Diarrhoea—Ramipril—coronary artery disease	5.81e-05	0.000241	CcSEcCtD
Rivaroxaban—Diarrhoea—Timolol—coronary artery disease	5.68e-05	0.000236	CcSEcCtD
Rivaroxaban—Hypersensitivity—Lisinopril—coronary artery disease	5.68e-05	0.000236	CcSEcCtD
Rivaroxaban—Dizziness—Ramipril—coronary artery disease	5.62e-05	0.000233	CcSEcCtD
Rivaroxaban—Asthenia—Lisinopril—coronary artery disease	5.53e-05	0.000229	CcSEcCtD
Rivaroxaban—Dizziness—Timolol—coronary artery disease	5.49e-05	0.000228	CcSEcCtD
Rivaroxaban—Pruritus—Lisinopril—coronary artery disease	5.45e-05	0.000226	CcSEcCtD
Rivaroxaban—Vomiting—Ramipril—coronary artery disease	5.4e-05	0.000224	CcSEcCtD
Rivaroxaban—Rash—Ramipril—coronary artery disease	5.36e-05	0.000222	CcSEcCtD
Rivaroxaban—Dermatitis—Ramipril—coronary artery disease	5.35e-05	0.000222	CcSEcCtD
Rivaroxaban—Headache—Ramipril—coronary artery disease	5.32e-05	0.000221	CcSEcCtD
Rivaroxaban—Vomiting—Timolol—coronary artery disease	5.28e-05	0.000219	CcSEcCtD
Rivaroxaban—Diarrhoea—Lisinopril—coronary artery disease	5.27e-05	0.000219	CcSEcCtD
Rivaroxaban—Rash—Timolol—coronary artery disease	5.24e-05	0.000217	CcSEcCtD
Rivaroxaban—Dermatitis—Timolol—coronary artery disease	5.23e-05	0.000217	CcSEcCtD
Rivaroxaban—Headache—Timolol—coronary artery disease	5.2e-05	0.000216	CcSEcCtD
Rivaroxaban—Dizziness—Lisinopril—coronary artery disease	5.1e-05	0.000211	CcSEcCtD
Rivaroxaban—Nausea—Ramipril—coronary artery disease	5.05e-05	0.000209	CcSEcCtD
Rivaroxaban—Nausea—Timolol—coronary artery disease	4.94e-05	0.000205	CcSEcCtD
Rivaroxaban—Vomiting—Lisinopril—coronary artery disease	4.9e-05	0.000203	CcSEcCtD
Rivaroxaban—Rash—Lisinopril—coronary artery disease	4.86e-05	0.000202	CcSEcCtD
Rivaroxaban—Dermatitis—Lisinopril—coronary artery disease	4.86e-05	0.000201	CcSEcCtD
Rivaroxaban—Headache—Lisinopril—coronary artery disease	4.83e-05	0.0002	CcSEcCtD
Rivaroxaban—Nausea—Lisinopril—coronary artery disease	4.58e-05	0.00019	CcSEcCtD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—coronary artery disease	1.2e-05	8.72e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—APOA2—coronary artery disease	1.2e-05	8.71e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PLA2G2A—coronary artery disease	1.2e-05	8.71e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—GPX2—coronary artery disease	1.2e-05	8.71e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—SULT1E1—coronary artery disease	1.19e-05	8.68e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—ABCG5—coronary artery disease	1.18e-05	8.61e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—HK1—coronary artery disease	1.18e-05	8.61e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—GPX4—coronary artery disease	1.18e-05	8.61e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—SULT1A1—coronary artery disease	1.18e-05	8.61e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CKM—coronary artery disease	1.17e-05	8.51e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PPAP2B—coronary artery disease	1.17e-05	8.51e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—UQCRFS1—coronary artery disease	1.17e-05	8.51e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—HADHA—coronary artery disease	1.17e-05	8.51e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—coronary artery disease	1.17e-05	8.49e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—GSTA1—coronary artery disease	1.15e-05	8.41e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—LPA—coronary artery disease	1.14e-05	8.31e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—HK2—coronary artery disease	1.14e-05	8.28e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—AKR1B1—coronary artery disease	1.14e-05	8.28e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PLCB3—coronary artery disease	1.11e-05	8.05e-05	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—PTGS2—coronary artery disease	1.1e-05	8.03e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—APOA5—coronary artery disease	1.09e-05	7.97e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—SLC27A1—coronary artery disease	1.09e-05	7.94e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PYGM—coronary artery disease	1.09e-05	7.91e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—SULT4A1—coronary artery disease	1.09e-05	7.91e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PDK4—coronary artery disease	1.09e-05	7.91e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ALDH6A1—coronary artery disease	1.09e-05	7.91e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CKMT2—coronary artery disease	1.09e-05	7.91e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Biological oxidations—POMC—coronary artery disease	1.08e-05	7.89e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—P4HB—coronary artery disease	1.07e-05	7.82e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—LCAT—coronary artery disease	1.07e-05	7.78e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—CPT1B—coronary artery disease	1.07e-05	7.78e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—PLG—coronary artery disease	1.06e-05	7.69e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PLA2G1B—coronary artery disease	1.05e-05	7.67e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—APOA4—coronary artery disease	1.05e-05	7.64e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—coronary artery disease	1.02e-05	7.4e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PDHA1—coronary artery disease	1.01e-05	7.38e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—GCLM—coronary artery disease	1.01e-05	7.38e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—VCAN—coronary artery disease	9.93e-06	7.23e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—ALDOA—coronary artery disease	9.85e-06	7.18e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—CYP11B2—coronary artery disease	9.81e-06	7.15e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—TXNRD1—coronary artery disease	9.81e-06	7.15e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—HMOX1—coronary artery disease	9.75e-06	7.1e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GK—coronary artery disease	9.69e-06	7.05e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PFKM—coronary artery disease	9.69e-06	7.05e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GYG1—coronary artery disease	9.69e-06	7.05e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—HMGCS2—coronary artery disease	9.69e-06	7.05e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—LDHA—coronary artery disease	9.69e-06	7.05e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GATM—coronary artery disease	9.69e-06	7.05e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—SLC22A3—coronary artery disease	9.66e-06	7.04e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—DCN—coronary artery disease	9.57e-06	6.97e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—ARNTL—coronary artery disease	9.52e-06	6.94e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—HADH—coronary artery disease	9.52e-06	6.94e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—APOB—coronary artery disease	9.34e-06	6.8e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—coronary artery disease	9.32e-06	6.79e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—ALDH2—coronary artery disease	9.31e-06	6.78e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GCH1—coronary artery disease	9.24e-06	6.73e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—AK1—coronary artery disease	9.24e-06	6.73e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—coronary artery disease	9.14e-06	6.66e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—LIPC—coronary artery disease	9.07e-06	6.6e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—HBA1—coronary artery disease	9.07e-06	6.6e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PIK3C2A—coronary artery disease	9.07e-06	6.6e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—CYP2C19—coronary artery disease	9.07e-06	6.6e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—GPX2—coronary artery disease	9.03e-06	6.58e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PLA2G2A—coronary artery disease	9.03e-06	6.58e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—APOA2—coronary artery disease	9.03e-06	6.58e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—APOC3—coronary artery disease	9.01e-06	6.56e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—LDLR—coronary artery disease	8.96e-06	6.52e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—GPX4—coronary artery disease	8.92e-06	6.5e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—ABCG5—coronary artery disease	8.92e-06	6.5e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—SULT1A1—coronary artery disease	8.92e-06	6.5e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—HK1—coronary artery disease	8.92e-06	6.5e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PLCD1—coronary artery disease	8.86e-06	6.45e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PPAT—coronary artery disease	8.86e-06	6.45e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—UGCG—coronary artery disease	8.86e-06	6.45e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—MDH2—coronary artery disease	8.86e-06	6.45e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—SLC9A1—coronary artery disease	8.85e-06	6.45e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—GSTT1—coronary artery disease	8.85e-06	6.45e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—HADHA—coronary artery disease	8.81e-06	6.42e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—CETP—coronary artery disease	8.75e-06	6.37e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—GCLC—coronary artery disease	8.75e-06	6.37e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—GSTA1—coronary artery disease	8.71e-06	6.34e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—coronary artery disease	8.71e-06	6.34e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—SDC1—coronary artery disease	8.65e-06	6.3e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—LPA—coronary artery disease	8.61e-06	6.27e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PGM1—coronary artery disease	8.53e-06	6.21e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PLCB3—coronary artery disease	8.34e-06	6.08e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—APOA5—coronary artery disease	8.26e-06	6.01e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PYGB—coronary artery disease	8.24e-06	6e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CKB—coronary artery disease	8.24e-06	6e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PSMA6—coronary artery disease	8.17e-06	5.95e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PSMB5—coronary artery disease	8.17e-06	5.95e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—P4HB—coronary artery disease	8.1e-06	5.9e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—CTGF—coronary artery disease	7.98e-06	5.81e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PLA2G1B—coronary artery disease	7.95e-06	5.79e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—coronary artery disease	7.93e-06	5.78e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—GOT2—coronary artery disease	7.91e-06	5.76e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—HMGCR—coronary artery disease	7.91e-06	5.76e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—DLAT—coronary artery disease	7.74e-06	5.64e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PFKFB3—coronary artery disease	7.74e-06	5.64e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GSTM2—coronary artery disease	7.74e-06	5.64e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PLIN1—coronary artery disease	7.74e-06	5.64e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—COX5B—coronary artery disease	7.74e-06	5.64e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—VCAN—coronary artery disease	7.49e-06	5.46e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—ALDOA—coronary artery disease	7.44e-06	5.42e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—APOA1—coronary artery disease	7.39e-06	5.38e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—SULT1E1—coronary artery disease	7.34e-06	5.35e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PLCB1—coronary artery disease	7.28e-06	5.3e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—DCN—coronary artery disease	7.22e-06	5.26e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—ABCA1—coronary artery disease	7.05e-06	5.14e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—ALDH2—coronary artery disease	7.02e-06	5.11e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—AKR1B1—coronary artery disease	7e-06	5.1e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—HK2—coronary artery disease	7e-06	5.1e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—HBA1—coronary artery disease	6.84e-06	4.98e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—LIPC—coronary artery disease	6.84e-06	4.98e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PIK3C2A—coronary artery disease	6.84e-06	4.98e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—CYP2C19—coronary artery disease	6.84e-06	4.98e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—GGT1—coronary artery disease	6.83e-06	4.97e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—GOT1—coronary artery disease	6.83e-06	4.97e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—APOC3—coronary artery disease	6.8e-06	4.95e-05	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—PIK3CA—coronary artery disease	6.78e-06	4.94e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—LDLR—coronary artery disease	6.76e-06	4.92e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—SLC27A1—coronary artery disease	6.71e-06	4.89e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—SLC9A1—coronary artery disease	6.68e-06	4.86e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—GSTT1—coronary artery disease	6.68e-06	4.86e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—CETP—coronary artery disease	6.6e-06	4.81e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—GCLC—coronary artery disease	6.6e-06	4.81e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—LCAT—coronary artery disease	6.58e-06	4.8e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CPT1B—coronary artery disease	6.58e-06	4.8e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—SDC1—coronary artery disease	6.53e-06	4.75e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—coronary artery disease	6.48e-06	4.72e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—APOA4—coronary artery disease	6.46e-06	4.71e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PDHA1—coronary artery disease	6.24e-06	4.55e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GCLM—coronary artery disease	6.24e-06	4.55e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PSMB5—coronary artery disease	6.17e-06	4.49e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PSMA6—coronary artery disease	6.17e-06	4.49e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—GSTP1—coronary artery disease	6.14e-06	4.47e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PPARGC1A—coronary artery disease	6.08e-06	4.43e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—HMOX1—coronary artery disease	6.05e-06	4.41e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CYP11B2—coronary artery disease	6.04e-06	4.4e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—TXNRD1—coronary artery disease	6.04e-06	4.4e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—CTGF—coronary artery disease	6.02e-06	4.39e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—HMGCR—coronary artery disease	5.97e-06	4.35e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—GOT2—coronary artery disease	5.97e-06	4.35e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—CAT—coronary artery disease	5.97e-06	4.35e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—SLC22A3—coronary artery disease	5.95e-06	4.34e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ARNTL—coronary artery disease	5.87e-06	4.27e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—HADH—coronary artery disease	5.87e-06	4.27e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—ALB—coronary artery disease	5.85e-06	4.26e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—APOB—coronary artery disease	5.8e-06	4.22e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—GSTM1—coronary artery disease	5.64e-06	4.11e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—APOA2—coronary artery disease	5.56e-06	4.05e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PLA2G2A—coronary artery disease	5.56e-06	4.05e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GPX2—coronary artery disease	5.56e-06	4.05e-05	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—AKT1—coronary artery disease	5.54e-06	4.04e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—LPL—coronary artery disease	5.53e-06	4.03e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ABCG5—coronary artery disease	5.49e-06	4e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GPX4—coronary artery disease	5.49e-06	4e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—SULT1A1—coronary artery disease	5.49e-06	4e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—HK1—coronary artery disease	5.49e-06	4e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PLCB1—coronary artery disease	5.49e-06	4e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—HADHA—coronary artery disease	5.43e-06	3.95e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—GPX1—coronary artery disease	5.4e-06	3.93e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GSTA1—coronary artery disease	5.37e-06	3.91e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—ABCA1—coronary artery disease	5.32e-06	3.88e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—LPA—coronary artery disease	5.31e-06	3.87e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—CD36—coronary artery disease	5.26e-06	3.83e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PPP2CA—coronary artery disease	5.19e-06	3.78e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—GGT1—coronary artery disease	5.15e-06	3.75e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—GOT1—coronary artery disease	5.15e-06	3.75e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PLCB3—coronary artery disease	5.14e-06	3.74e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—APOA5—coronary artery disease	5.09e-06	3.71e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—P4HB—coronary artery disease	4.99e-06	3.63e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—MTHFR—coronary artery disease	4.98e-06	3.63e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	4.9e-06	3.57e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—AGT—coronary artery disease	4.73e-06	3.45e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—APOE—coronary artery disease	4.64e-06	3.38e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—GSTP1—coronary artery disease	4.63e-06	3.37e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—VCAN—coronary artery disease	4.62e-06	3.36e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PPARGC1A—coronary artery disease	4.59e-06	3.34e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—APOA1—coronary artery disease	4.59e-06	3.34e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ALDOA—coronary artery disease	4.58e-06	3.34e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—HMOX1—coronary artery disease	4.57e-06	3.33e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—CAT—coronary artery disease	4.5e-06	3.28e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—DCN—coronary artery disease	4.45e-06	3.24e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—APOB—coronary artery disease	4.37e-06	3.19e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ALDH2—coronary artery disease	4.33e-06	3.15e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—GSTM1—coronary artery disease	4.25e-06	3.1e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—LIPC—coronary artery disease	4.22e-06	3.07e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—HBA1—coronary artery disease	4.22e-06	3.07e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	4.22e-06	3.07e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CYP2C19—coronary artery disease	4.22e-06	3.07e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—APOC3—coronary artery disease	4.19e-06	3.05e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—LPL—coronary artery disease	4.18e-06	3.04e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—LDLR—coronary artery disease	4.16e-06	3.03e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—SLC9A1—coronary artery disease	4.11e-06	3e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GSTT1—coronary artery disease	4.11e-06	3e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—GPX1—coronary artery disease	4.07e-06	2.97e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GCLC—coronary artery disease	4.07e-06	2.96e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CETP—coronary artery disease	4.07e-06	2.96e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PPARG—coronary artery disease	4.04e-06	2.94e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—SDC1—coronary artery disease	4.02e-06	2.93e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—POMC—coronary artery disease	3.98e-06	2.9e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—CD36—coronary artery disease	3.97e-06	2.89e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PPP2CA—coronary artery disease	3.92e-06	2.85e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PSMA6—coronary artery disease	3.8e-06	2.77e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PSMB5—coronary artery disease	3.8e-06	2.77e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—MTHFR—coronary artery disease	3.76e-06	2.74e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CTGF—coronary artery disease	3.71e-06	2.7e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GOT2—coronary artery disease	3.68e-06	2.68e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—HMGCR—coronary artery disease	3.68e-06	2.68e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—ALB—coronary artery disease	3.63e-06	2.65e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—AGT—coronary artery disease	3.57e-06	2.6e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—APOE—coronary artery disease	3.5e-06	2.55e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—NOS3—coronary artery disease	3.48e-06	2.53e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—APOA1—coronary artery disease	3.46e-06	2.52e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PLCB1—coronary artery disease	3.38e-06	2.46e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ABCA1—coronary artery disease	3.28e-06	2.39e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PTGS2—coronary artery disease	3.18e-06	2.31e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GGT1—coronary artery disease	3.18e-06	2.31e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GOT1—coronary artery disease	3.18e-06	2.31e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PPARG—coronary artery disease	3.05e-06	2.22e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—POMC—coronary artery disease	3.01e-06	2.19e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GSTP1—coronary artery disease	2.85e-06	2.08e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	2.83e-06	2.06e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—HMOX1—coronary artery disease	2.81e-06	2.05e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CAT—coronary artery disease	2.78e-06	2.02e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—ALB—coronary artery disease	2.74e-06	2e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—APOB—coronary artery disease	2.69e-06	1.96e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—NOS3—coronary artery disease	2.62e-06	1.91e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GSTM1—coronary artery disease	2.62e-06	1.91e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—LPL—coronary artery disease	2.57e-06	1.87e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GPX1—coronary artery disease	2.51e-06	1.83e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CD36—coronary artery disease	2.44e-06	1.78e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PPP2CA—coronary artery disease	2.41e-06	1.76e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PTGS2—coronary artery disease	2.4e-06	1.75e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—MTHFR—coronary artery disease	2.32e-06	1.69e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—AGT—coronary artery disease	2.2e-06	1.6e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—APOE—coronary artery disease	2.16e-06	1.57e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—APOA1—coronary artery disease	2.13e-06	1.55e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PIK3CA—coronary artery disease	1.96e-06	1.42e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PPARG—coronary artery disease	1.88e-06	1.37e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—POMC—coronary artery disease	1.85e-06	1.35e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ALB—coronary artery disease	1.69e-06	1.23e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—NOS3—coronary artery disease	1.62e-06	1.18e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—AKT1—coronary artery disease	1.6e-06	1.16e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PTGS2—coronary artery disease	1.48e-06	1.08e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PIK3CA—coronary artery disease	1.48e-06	1.07e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—AKT1—coronary artery disease	1.21e-06	8.78e-06	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PIK3CA—coronary artery disease	9.09e-07	6.62e-06	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—AKT1—coronary artery disease	7.43e-07	5.41e-06	CbGpPWpGaD
